Endocrine Disruptors

This conference delves right into the ongoing debate surrounding the complex identification of endocrine disruptors and the implementation of EU guidance documents. It offers participants valuable insights into the latest regulatory and scientific advancements.

25.11. — 26.11.2025
Live Stream
 Termin speichern
Platz vorreservierenBuchen

ÜbersichtProgrammReferent:innenVeranstaltungsortPreise & Leistungen

Übersicht

The ECHA/EFSA guidance for the identification of Endocrine Disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009 requires a highly complex and challenging assessment for all active substances. With the new hazard classes for EDs under the CLP regulation, the challenge has recently been broadened. This conference will dive right into the debate surrounding Endocrine Disruptors and covers all the latest relevant regulatory and scientific developments.

The Conference will be taking place in Dusseldorf/Germany on 25 and 26 November 2025 and you can follow all the exciting contributions via our live stream!

Would you instead prefer to join on-site in Dusseldorf? Then you can find further information here.

Early Bird Bookings10% discount valid until 30 September 2025 with discount code: ENDOCRINE10

Highlights

Regulatory Developments and Future Perspectives

  • ECHA on the implementation of the new CLP hazard classes for endocrine disruptors
  • EDs under REACH and CLP: Experience from German UBA and BASF
  • Outlook on REACH revision and GHS-related activities
  • Pesticides: Updates and experience reports from the EU Commission, ANSES, and industry

Next Generation Testing and Innovative Methods

  • BfR on current regulatory acceptance of NAMs
  • Readiness of new ED testing methods
  • Thyroid: Increasing confidence in the human thyroid microtissue assay
  • Using AI: From QSAR predictions to LLM evidence summarisation

Developments in Ecotoxicology

  • The SETAC MAPPED initiative
  • Tiered assessment schemes linking NAMs to adverse outcomes in aquatic vertebrates

Beyond EATS: New Pathways and European Initiatives

  • Next generation risk assessment of obesogenic chemicals: GOLIATH project findings and updates on PARC and AFARA initiatives
  • Metabolism-disrupting chemical testing: Advances in methodology and future direction

Who should attend this conference?

Professionals working in the fields of:

  • Toxicology and ecotoxicology
  • Research and development
  • Registration and regulatory affairs
  • Chemical risk assessment
  • Legal and general counselling

Sectors that should take part:

  • Chemical/biocide/agrochemical/pharmaceutical/cosmetic industries
  • Research institutes
  • Regulatory authorities
  • Environmental and health risk consultants
  • Testing laboratories and contract research organisations (CROs)
  • NGOs

Picture Credit: © Subbotina Anna/shutterstock.com, © chestra - Fotolia.com

 

Programm

Tuesday, 25 November 2025

Timings are in Central European Time CET.



Morning Session | 09:00 – 12:35 CET
08:30
On-site registration and opening of the virtual meeting room
09:00
Welcome address by the organisers and the Chairs

Lennart Weltje, BASF, Germany
Emily McVey, National Institute for Public Health and the Environment (RIVM), The Netherlands

Regulatory Developments and Future Perspectives
09:10
Implementation of the new CLP hazard classes for endocrine disruptors
  • Classification of endocrine disruptors under the CLP regulation
  • ECHA CLP guidance on endocrine disruptors
  • Future work by the ECHA ED Expert Group and RAC on endocrine disruptors

Kirsi Myöhänen, European Chemicals Agency (ECHA), Finland (virtually)

09:45
Environmental EDs under REACH – Processes, integration of CLP and perspectives
  • Environmental ED assessment
  • CLP implications
  • Outlook: REACH revision and GHS-related activities

Jürgen Arning, German Environment Agency (UBA), Germany

10:20
Case study on Geraniol: Critical assessment of potential endocrine activity on the thyroid modality and downstream adversities
  • Human relevance of potential direct and indirect thyroid effects in vivo, with regulatory implications for REACH, CLP, Biocides, and Pesticides
  • Species differences in liver enzyme induction and the question of human relevancy
  • Guidance on assessing human relevance and species differences with NAMs and challenges in classification under the CLP ED criteria

Markus Wahl, BASF, Germany

10:55
Coffee break
11:25
Accepting the challenge: Quantitative risk assessment for ED substances with a focus on human health – Initial results and potential way(s) forward
  • Development of a guidance for quantitative human health risk assessment for ED substances by the CEFIC Sector Group Biocides for Europe
  • Presentation of initial results

Anette Thiel, Ramboll, Germany

12:00
Update on the regulatory processes under Regulation (EC) No 1107/2009
  • Status of the active substances under the PPP Regulation, including the specific conditions of approvals
  • Recent developments in the field, including developments related to ED

Nikolay Tzvetkov, European Commission, Belgium (virtually)

12:35
Lunch break


Afternoon Session | 13:45 – 18:00 CET
13:45
Member State experience with ED assessments for pesticides

Pierre-François Chaton, French Agency for Food, Environ-mental and Occupational Health & Safety (ANSES), France

14:20
Experience and perspectives from the pesticide industry

Member of CropLife Europe (confirmed)

14:55
Environmental risk assessment of endocrine-active human pharmaceuticals

ZhiChao Dang, National Institute for Public Health and the Environment (RIVM), The Netherlands

15:30
Coffee break
Developments in Ecotoxicology
16:00
Assessing population relevance of endocrine disrupting effects in fish an amphibians: The SETAC MAPPED initiative
  • Population relevance under the ECHA/EFSA ED criteria
  • Applying population models to explore the relevance of individual-level responses in standard ecotoxicological tests from endocrine modalities in fish and amphibians
  • Identification of focal species and practical applications of population modelling

Valery E. Forbes, Florida Atlantic University, United States of America

16:35
Tiered assessment schemes linking NAMs to adverse outcomes to identify endocrine disruptors in aquatic vertebrates
  • Linking in vitro responses to individual-level adverse outcomes, and further to population-level responses, using coherent, evidence-based tiered assessment schemes
  • Using the assessment of the thyroid modality in amphibians as an example of decision logic to navigate through tier testing
  • Forward-looking thinking towards a fish-based tiered assessment scheme for EAS (Estrogen/Androgen/Steroidogenesis) modality

Laurent Lagadic, Bayer, Germany

Next Generation Testing and Innovative Methods
17:10
Advancing the acceptance and use of the human thyroid microtissue assay
  • Filling technology gaps for in vitro thyroid testing
  • Increasing confidence in the human thyroid microtissue assay as a new approach method
  • Integration of thyroid microtissues into an AOP-based tiered screening paradigm to support the context of use

Chad Deisenroth, U.S. Environmental Protection Agency (EPA), United States of America (virtually)

17:45
Final discussion
18:00
End of the first day


Wednesday, 26 November 2025

Timings are in Central European Time CET.



Morning Session | 09:00 – 13:10 CET
09:00
Brief address by the Chairs

Lennart Weltje, BASF, Germany
Emily McVey, National Institute for Public Health and the Environment (RIVM), The Netherlands

Next Generation Testing and Innovative Methods
09:10
The PEPPER experiences with ring-trial validation of methods in the ED space
  • Requirements and readiness of ED test methods
  • Organising validation projects
  • Submission and review under the OECD TG system

Torben Österlund, Public-private platform for the validation of endocrine disruptors characterization methods (PEPPER), France

09:45
Current status of the regulatory acceptance of NAMs for ED assessment
  • Applicability of read-across to evaluate adversity under plant protection and biocidal products regulation
  • Further efforts needed for a harmonised and stand-alone NAM-based approach to predict adverse endocrine effects
  • More research to improve the in vitro detection of non-EATS mechanisms

Denise Bloch, German Federal Institute for Risk Assessment (BfR), Germany

10:05
Case studies in assessing the endocrine disruption capabilities of cosmetics ingredients without new animal testing serving REACH and cosmetic product regulation requirements

Karma Fussell, Wella, Germany

10:40
Coffee break
11:10
From QSAR predictions to LLM evidence summarisation: Using AI for endocrine disruptor assessment
  • Predictive AI: Use of QSARs and machine learning for predicting endocrine activity to safety assessment
  • Large Language Models (LLMs): Role of LLMs in summarising scientific evidence, literature, and mechanistic data to support decision-making
  • Addressing explainability, accountability, and transparency as critical elements for applying AI in toxicology

Arianna Bassan, Innovatune, Italy

Beyond EATS: New Pathways and European Initiatives
11:45
From data gaps to detection: PARC’s contributions to metabolism-disrupting chemical testing
  • Critical data gaps related to key substance groups, including PFAS and bisphenol analogues
  • Methodological advancements for the detection of metabolism-disrupting chemicals
  • Findings and way forward

Denise Bloch, German Federal Institute for Risk Assessment (BfR), Germany

12:20
Next generation risk assessment of obesogenic chemicals in chemical regulation
  • Findings from the GOLIATH project (IATA and prevalidation work, chemical selection)
  • Ongoing work in PARC and the AFARA project
  • Moving further towards Defined Approaches or IATAs

Jorke Kamstra, Utrecht University, The Netherlands

12:55
Summary and final discussion
13:10
End of the conference

Referent:innen

 

Name

Unternehmen

Arning

Jürgen Arning

German Environment Agency (UBA), Germany

Jürgen Arning holds a PhD in Biochemistry and works as a Regulatory Scientist at the German Federal Environment Agency. His main tasks comprise the identification and evaluation of endocrine disruptors in the environment under the REACH framework. Additionally, he is involved in initiating risk management measures for environmental ED and in accompanying scientific research projects. Since 2015 he has been a member of the ECHA Endocrine Disruptors Expert Group.

mehrweniger
Bassan

Arianna Bassan

Innovatune, Italy

Arianna Bassan is a consultant and European Registered Toxicologist (ERT) with a multidisciplinary background in chemistry, biology, and toxicology. As co-founder of Innovatune, she specializes in human health hazard assessment integrating  (Q)SAR, read-across, and computational methods. She has led international groups on in silico toxicology and is now extending this work to AI-based toxicological risk assessment. She is the author of numerous peer-reviewed publications and reports.

mehrweniger

Denise Bloch

German Federal Institute for Risk Assessment (BfR), Germany

Denise Bloch heads the Junior Research Group “New Approach Methodology (NAM)-based assessment of mixtures” at the German Federal Institute for Risk Assessment (BfR). Her research is focused on improving the human health risk assessment of mixtures by the application of alternatives to animal testing. In the past, she has worked as a regulator in the zonal authorisation of plant protection products at BfR (DE), conducted research on active transport inhibition at the Helmholtz Centre for Environmental Research in Leipzig (DE) and has studied biogeochemistry at ETH Zurich (CH).

mehrweniger
Chaton

Pierre-François Chaton

French Agency for Food, Environmental and Occupational Health and Safety (ANSES), France

Pierre-François Chaton is Deputy Head of the Ecotoxicology and Environmental Fate Unit and a Senior Risk Assessor in ecotoxicology at the French Agency for Food, Environmental and Occupational Health and Safety (ANSES). He has more than 18 years of experience in regulatory risk assessment of plant protection products, including method development.

mehrweniger
Dang

ZhiChao Dang

National Institute for Public Health and the Environment (RIVM), The Netherlands

ZhiChao Dang is EU Registered Toxicologist and Senior Risk Assessor and Project Coordinator at the Dutch National Institute for Public Health and the Environment (RIVM). He has an extensive track record in laboratory work focusing on endocrine regulation in animals and in regulating endocrine disruptors. His PhD study centred on the stress response in fish. Subsequently, he conducted research on phytoestrogens and metabolic diseases such as osteoporosis, obesity and diabetes, employing in vitro cell culture, molecular techniques and mammalian models at the Department of Endocrinology and Metabolic Diseases in Leiden University Medical Center. Over the past two decades, he has been actively involved in developing test methods, testing strategy and risk assessment of chemicals such as pharmaceuticals and industrial chemicals. He has served as a member of expert groups for several international organisations including OECD EDTA AG, OECD VMG Eco, OECD VMG NA, EU ED EAG, ECHA PEG for CLP, and EFSA EDEG. Additionally, he has contributed to discussions in the ECHA EDEG and BPC EG, providing input on guidance documents and on identification of endocrine disruptors.

mehrweniger
Deisenroth

Chad Deisenroth

U.S. Environmental Protection Agency (EPA), United States of America

Chad Deisenroth holds a Ph.D. in Genetics and Molecular Biology and joined the U.S. Environmental Protection Agency in 2016 as a Cell Biologist in the Center for Computational Toxicology and Exposure. He leads a research team focused on developing in vitro methods for high-throughput screening and complex culture models with an emphasis on endocrine toxicity, xenobiotic metabolism, and developmental toxicity. Previously, he was a Principal Investigator at the Hamner Institutes for Health Sciences where he developed complex culture models and methods for evaluating metabolic disease and liver carcinogenesis. He has a particular interest in developing new approach methods to replace animal testing and is a member of the OECD Thyroid Disruption Methods Expert Group.

mehrweniger
Forbes

Valery E. Forbes

Florida Atlantic University, United States of America

Valery E. Forbes has been Professor in the Department of Biological Sciences and Dean of the Charles E. Schmidt College of Science at Florida Atlantic University since 2022. Previously, she served as Dean of the College of Biological Sciences at University of Minnesota, Director of the School of Biological Sciences at University of Nebraska-Lincoln, and Founding Head of the Department of Environmental, Social and Spatial Change at Roskilde University in Denmark. Her specific research topics include population ecology and modelling, fate and effects of toxic chemicals in sediments, and ecological risk assessment. She was work package leader of the EU Marie Curie Training Programme on mechanistic effect modelling (CREAM) from 2009 to 2014 and has served on the Danish Natural Sciences Research Council, the European Research Council, NATO’s Environmental Security Panel, and as ad hoc reviewer for numerous funding agencies from various countries.

mehrweniger

Karma Fussell

Wella, Germany

Karma Fussell holds a PhD in Toxicology and joined Wella Company in 2024 as a Senior Principal Toxicologist responsible for the safety of the hair dye portfolio.  She is a Diplomate of the American Board of Toxicology, with more than 10 years of experience developing methods, conducting studies and assessing safety, especially for endocrine active substances. Before joining Wella, Karma worked on ED topics for the food, plant protection and chemical industries and has participated in several international product safety groups. She is the author of numerous peer-reviewed publications and reports.

mehrweniger
Kamstra

Jorke Kamstra

Utrecht University, The Netherlands

Jorke Kamstra is Associate Professor of Toxicology at Utrecht University, where he leads the Endocrine Toxicology group. His research focuses on molecular mechanisms of endocrine and metabolism disrupting chemicals, the development of in vitro assays and zebrafish models, and their application in next-generation risk assessment. He is actively involved in several European research consortia and in the validation of new test methods for regulatory use.

mehrweniger
Lagadic

Laurent Lagadic

Bayer, Germany

Laurent Lagadic has been working in the Environmental Safety Division of Bayer CropScience in Germany for over 10 years. He currently leads the development and application of testing strategies for evaluating potential endocrine disrupting properties of pesticides and biocides for the environment. He holds a PhD in fundamental and environmental toxicology and has previously worked as an Aquatic Ecotoxicologist at the French National Research Institute for Agriculture, Food and Environment (INRAE) for over 20 years.

mehrweniger
McVey

Emily McVey

National Institute for Public Health and the Environment (RIVM), The Netherlands

Emily McVey is an experienced Regulatory Toxicologist and works at the Dutch National Institute for Public Health and the Environment – RIVM. Her specialties include environmental toxicology, wild vertebrates (birds, mammals, amphibians, fish), molecular mechanisms of toxicity, neurodevelopmental toxicity and endocrine disruption testing and assessment.

mehrweniger
Myöhänen

Kirsi Myöhänen

European Chemicals Agency (ECHA), Finland

Kirsi Myöhänen is a Scientific Officer Unit (C1 Classification) of the European Chemicals Agency ECHA. A toxicologist (PhD Pharm, MSC Pharm, and MSC Tox, European Registered Toxicologist) by trainings, she has been working in ECHA Classification unit from 2012, in ECHA Biocides unit in 2013-2019 with biocidal active substance approval and since 2019 again in classification, where she has also been involved in developing classification criteria for EDs. Kirsi is also a co-chair of the ECHA Endocrine Disruptor Expert Group (ED EG). She has previously worked as Senior Adviser at the Finnish Safety and Chemicals Agency involved also in developing ED criteria for biocides and PPPs.

mehrweniger
Thiel

Anette Thiel

Ramboll, Germany

Anette Thiel is a Food Chemist and acquired her PhD in toxicology/endocrine disruption from the University of Kaiserslautern on the influence of metabolism on endocrine activity. She is Eurotox Registered Toxicologist and a Diplomate of the American Board of Toxicology and specialized in ED assessments. Anette has more than 20 years of experience in toxicology in industry and consulting. Before joining Ramboll - SCC in September 2020 as a group leader for Human Health Risk Assessment and Toxicology topics for biocides, she worked for DSM Nutritional Products in Switzerland being responsible for ED topics.

mehrweniger
Tzvetkov

Nikolay Tzvetkov

European Commission, Belgium

Nikolay Kirilov Tzvetkov holds two Master's degrees from Sofia University in Biochemistry and Genetic and Cell Engineering and has been working as a Policy Officer for the Pesticides and Biocides Unit at DG SANTE since 2021. Previously, he worked as a Policy Officer in the Biodiversity Unit at Bulgaria's Ministry of Environment and Water and as a Research Scientist at institutions in Germany and Japan. 

mehrweniger
Wahl

Markus Wahl

BASF, Germany

Markus Wahl (PhD) studied biology with a focus on molecular plant physiology, biochemistry and molecular cell biology. He is a registered Toxicologist (DGPT, ERT) and has been working for BASF since 2008, currently as an Expert in Global Regulatory Affairs for Aroma Ingredients.

mehrweniger
Weltje

Lennart Weltje

BASF, Germany

Lennart Weltje holds a PhD in ecotoxicology and environmental chemistry and currently works as a Senior Ecotoxicologist at BASF conducting risk assessments for PPPs and biocides. He is also an honorary Professor at the Faculty of Agricultural Sciences of the Georg-August University in Goettingen. His former stations include the Dutch National Institute for Public Health and the Environment (RIVM).

mehrweniger
Österlund

Torben Österlund

PEPPER, France

Torben Österlund joined Pepper in July 2024 as Chief Scientific Officer with responsibilities for all scientific aspects of method validation. Pepper pools public and private resources to organizes validation of bioassays bridging the gap between academic research and regulatory science. Torben has for 3 decades worked in academia, biotech and pharma based in bioassays for research, chemical efficacy and safety/toxicology. He has strong experience with early pharmaceutical discovery and safety sciences, and recently worked with new approach methods (NAMs) in different areas of toxicology.

mehrweniger

Veranstaltungsort

Live Stream
On-site conference is going to be streamed live.
You can reach us directly at:
Telefon : +49 231 75896-50
E-Mail: info@akademie-fresenius.de
https://www.akademie-fresenius.com/

Preise & Leistungen

Teilnahmepreis: € 1.195,00 zzgl. MwSt.

Im Teilnahmepreis sind folgende Leistungen enthalten:

  • Teilnahme an der Online-Veranstaltung
  • Veranstaltungsdokumentation zum Download
  • Teilnahmezertifikat

Vertreter:innen einer Behörde oder einer öffentlichen Hochschule erhalten einen ermäßigten Teilnahmepreis von € 695,00 zzgl. MwSt. (Nachweis per Fax oder E-Mail erforderlich). Der Sonderpreis ist nicht mit anderen Rabatten kombinierbar.

Gruppenrabatt
Bei gemeinsamer Anmeldung aus einem Unternehmen erhalten die dritte und jede weitere Person 15 % Rabatt.

Buchen ohne Risiko
Die Teilnahme an unseren Online-Veranstaltungen können Sie bis zu 1 Woche vor Veranstaltungsbeginn kostenfrei und ohne Angabe von Gründen schriftlich stornieren. Bei späteren Stornierungen sowie bei Nicht-Login zur Online-Veranstaltung können keine Teilnahmegebühren erstattet werden.
Sie erhalten jedoch in diesem Fall von uns nach der Veranstaltung Zugang zu den Dokumentationsunterlagen.
Eine Ersatzperson können Sie jederzeit kostenfrei benennen.

Veranstaltungsdokumentation

Wären Sie gern dabei gewesen, sind jedoch zeitlich verhindert?

Zum Preis von 295,00 € zzgl. MwSt. können Sie alle Vorträge als pdf zum Download bestellen. Sie erhalten dann einige Tage nach der Veranstaltung die Zugangsdaten zum Downloadbereich unserer Website. Dort finden Sie alle Vorträge in digitaler Form (die Zustimmung der Referent:innen vorausgesetzt) und in der aktuellsten Version.

Dokumentation bestellen

Claudia Werner

Ihre Ansprechpartnerin

Claudia Werner
Inhalt und Konzeption

+49 231 75896-83
cwerner@akademie-fresenius.de

Claudia Werner

Ihre Ansprechpartnerin

Claudia Werner
Inhalt und Konzeption

+49 231 75896-83
cwerner@akademie-fresenius.de

Claudia Werner

Ihre Ansprechpartnerin

Claudia Werner
Inhalt und Konzeption

+49 231 75896-83
cwerner@akademie-fresenius.de

Alexandra Schardt

Ihre Ansprechpartnerin

Alexandra Schardt
Organisation und Teilnehmermanagement

+49 231 75896-74
aschardt@akademie-fresenius.de

Alexandra Schardt

Ihre Ansprechpartnerin

Alexandra Schardt
Organisation und Teilnehmermanagement

+49 231 75896-74
aschardt@akademie-fresenius.de

Weitere Termine für diese Veranstaltung:

25.11. — 26.11.2025,  Novotel Düsseldorf City West

Fachausstellung buchen

Präsentieren Sie Ihr Unternehmen auf unserer Veranstaltung.

Persönlich und zielgruppengenau stellen Sie Ihre Produkte und Dienstleistungen vor. Gerne informieren wir Sie unverbindlich über die verschiedenen Möglichkeiten – von der Auslage von Produktinformationen bis hin zum Ausstellungsstand.

Gerne beraten wir Sie persönlich:

Monika Stratmann

Monika Stratmann
Telefon: +49 231 75896-48
info@akademie-fresenius.de

Pressekontakt

Wir bieten Journalist:innen und Redakteur:innen eine Plattform, um in Kontakt mit Expert:innen zu treten.

Wenn Sie als Redakteur:in der Fachpresse Interesse an einem Pressepass oder einer Medienpartnerschaft haben, kontaktieren Sie uns bitte frühzeitig. Wir beraten Sie gerne.


Sprechen Sie uns an:

Katharina Geraridis

Katharina Geraridis
Telefon: +49 231 75896-67
presse@akademie-fresenius.de

Bildergalerie